Nitrous Acid

Nitrous Acid

SCHEMBL4556970

O=NO.c1ccc(CCc2ccccc2)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.56
TDP1 Q9NUW8 3/20 0.55
KEAP1 Q14145 1/20 0.54
HDAC1 Q13547 3/20 0.50
ALDH1A1 P00352 2/20 0.50
MAOA P21397 2/20 0.50
MAOB P27338 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HDAC2 Q92769 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
HDAC3 O15379 1/20 0.50
MAPK1 P28482 1/20 0.50
ADRA1A P35348 1/20 0.50
HDAC4 P56524 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylethyl Alcohol SCHEMBL27464884 0.87 TDP1 (0.76) FFAR1TDP1KEAP1HDAC1ALDH1A1
Phenethylamine SCHEMBL154732 0.85 TAAR1 (0.73) TDP1ALDH1A1MAOAMAOBSMN1; SMN2
Hydrogen Peroxide SCHEMBL10839772 0.85 TDP1 (0.71) FFAR1TDP1KEAP1HDAC1ALDH1A1
Hydrogen Peroxide SCHEMBL10839871 0.85 TDP1 (0.71) FFAR1TDP1KEAP1HDAC1ALDH1A1
Hydrocinnamyl Alcohol SCHEMBL28276928 0.84 TDP1 (0.56) TDP1KEAP1HDAC1MAOAMAOB
SCHEMBL9421220 0.83 MAOA (0.56) FFAR1TDP1KEAP1ALDH1A1MAOA
Phenyl Propionic Acid SCHEMBL6420576 0.82 KEAP1 (0.79) FFAR1TDP1KEAP1HDAC1ALDH1A1
SCHEMBL9741303 0.82 ALDH1A1 (0.69) FFAR1TDP1KEAP1ALDH1A1MAOA
SCHEMBL62125 0.82 ALDH1A1 (0.69) FFAR1TDP1KEAP1ALDH1A1MAOA
Benzene SCHEMBL3440179 0.82 ALDH1A1 (0.69) FFAR1TDP1KEAP1ALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115494145-A Detection method for crude oil maturity and application of N-substituted thiophene organic salt 中国石油天然气股份有限公司 2022-12-20 CN claimed
CN-115651206-A Cage-shaped synthetic supramolecular material, preparation method and application thereof 广州大学 2023-01-31 CN disclosed
CN-115651206-A Cage-shaped synthetic supramolecular material, preparation method and application thereof 广州大学 2023-01-31 CN disclosed
CN-115494145-A Detection method for crude oil maturity and application of N-substituted thiophene organic salt 中国石油天然气股份有限公司 2022-12-20 CN disclosed
CN-111595932-A Method for separating and analyzing trace metalloporphyrin in condensate oil 中国石油天然气股份有限公司 2020-08-28 CN disclosed
CN-111574402-A Preparation method of fluorescent material 江苏畅鸿新材料科技有限公司 2020-08-25 CN disclosed
US-20090105347-A1 THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-04-23 US disclosed
CN-101289428-A Biaryl substituted triazoles as sodium channel blockers MERCK & CO INC (US) 2008-10-22 CN disclosed
US-7355079-B2 Thyronamine derivatives and analogs and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-04-08 US disclosed
US-7321065-B2 Thyronamine derivatives and analogs and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-01-22 US disclosed
EP-1625111-A4 THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF UNIV CALIFORNIA (US) 2007-04-25 EP disclosed
CN-1898198-A Alpha-hydroxy amides as bradykinin antagonists or inverse agonists MERCK & CO INC (US) 2007-01-17 CN disclosed
CN-1788002-A Biaryl substituted triazoles as sodium channel blockers MERCK & CO INC (US) 2006-06-14 CN disclosed
US-20060035980-A1 Thyronamine derivatives and analogs and methods of use thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-02-16 US disclosed
EP-1625111-A2 THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-02-15 EP disclosed
US-20050096485-A1 Thyronamine derivatives and analogs and methods of use thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-05-05 US disclosed
WO-2004093800-A2 THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2004-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105347-A1 THYRONAMINE DERIVATIVES AND ANALOGS AND METHODS OF USE THEREOF TPO, TSHR, THRB FFAR1 1840/4885TDP1 1237/4885KEAP1 3010/4885
US-20060035980-A1 Thyronamine derivatives and analogs and methods of use thereof TPO, TSHR, THRB FFAR1 1794/4885TDP1 989/4885KEAP1 3047/4885
US-20050096485-A1 Thyronamine derivatives and analogs and methods of use thereof TPO, TSHR, THRB FFAR1 1840/4885TDP1 1237/4885KEAP1 3010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.